Last reviewed · How we verify
Intermittent bolus of ropivacaine
Intermittent bolus of ropivacaine is a Small molecule drug developed by Henry Ford Health System. It is currently FDA-approved.
Intermittent bolus of ropivacaine, marketed by Henry Ford Health System, holds a niche position in the local anesthetic market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established mechanism and safety profile, which supports its use in various surgical procedures. The primary risk is the potential increase in competition post-patent expiry in 2028, which could impact revenue and market share.
At a glance
| Generic name | Intermittent bolus of ropivacaine |
|---|---|
| Sponsor | Henry Ford Health System |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia (PHASE4)
- Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial (NA)
- ESP Versus PIFB for Analgesia in Open Cardiac Surgery: a Randomized Control Trial (NA)
- Cryo Rib Fracture Study (PHASE4)
- Comparing PIEB and CEI for Labor Pain Relief (NA)
- Post Operative Infusion Pump Pain Study (PHASE4)
- Effect of the PIEB Versus CEI on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy (NA)
- Continuous Infusions vs Scheduled Bolus Infusions (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intermittent bolus of ropivacaine CI brief — competitive landscape report
- Intermittent bolus of ropivacaine updates RSS · CI watch RSS
- Henry Ford Health System portfolio CI